COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 10:00, il y a 2 années 4 mois Formycon and Fresenius Kabi reach settlement agreement for ustekinumab biosimilar candidate FYB202 in Europe and Canada Formycon and Fresenius Kabi reach settlement agreement with Johnson & Johnson for ustekinumab biosimilar FYB202 in Europe and Canada. Agreement terms kept confidential. Focus on expanding patient access and ensuring reliable treatment options Settlement Agreement Biosimilar Formycon Fresenius Kabi Ustekinumab
COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 09:24, il y a 2 années 4 mois ESPG bond: More than 50% of bondholders have registered for written voting procedure – voting period is LIVE as of now ESPG bondholders show strong participation in written voting procedure, aiming to reach quorum. Voting period now live with key decisions to be made, encouraging all to exercise their voting rights Real Estate Bondholders Quorum ESPG Bond Voting Procedure
COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 09:20, il y a 2 années 4 mois Turkiye Garanti Bankasi A.S.: Announcement regarding Fitch Ratings Turkiye Garanti Bankasi A.S. announces Fitch Ratings upgrade on Long-Term IDRs & Debt ratings to 'B' & 'B-', with positive outlooks Positive Outlook Turkiye Garanti Bankasi A.S. Fitch Ratings Upgrade Long-Term IDRs
COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 09:02, il y a 2 années 4 mois Original-Research: Multitude SE (von NuWays AG): BUY Multitude SE reported strong Q4 figures and reaffirmed its FY24 EBIT guidance of €67.5m. Sales increased by 15% yoy to €63.1m, driven by net loan book growth. Analyst recommends BUY with a target price of €10 Buy Recommendation Sales Growth FY24 Guidance Multitude SE Q4 Figures
COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 09:01, il y a 2 années 4 mois Original-Research: Borussia Dortmund GmbH & Co KGaA (von NuWays AG): BUY Update on Borussia Dortmund GmbH & Co KGaA from NuWays AG highlights expected benefits from structural changes including Bundesliga broadcasting rights and new UCL format. Sponsorship upside and recent UCL success also contribute to positive outlook NuWays AG Sponsors Borussia Dortmund GmbH & Co KGaA Bundesliga UCL
COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 09:00, il y a 2 années 4 mois STAIDIUM U.S. and CALUVA Partner to Level the Playing Field in Sports Recruiting STAIDIUM U.S. partners with CALUVA to revolutionize sports recruiting by integrating AI-powered streaming technology to showcase young athletes worldwide to coaches and scouts STAIDIUM U.S. CALUVA Sports Recruiting AI-powered Streaming Technology Athlete Discovery Platform
COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 08:30, il y a 2 années 4 mois Mabilo Stage 1 Cost Update RTG Mining Inc. provides cost update for Stage 1 of the Mabilo Project in The Philippines, with Capital Costs remaining below US$25M. Operating Costs have reduced slightly, maintaining strong financials Financials Philippines RTG Mining Inc. Mabilo Project Cost Update
COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 08:15, il y a 2 années 4 mois Troy Minerals Acquires BC Property with REE Potential Troy Minerals Inc. announces the completion of staking a new property highly prospective for rare-earth elements in British Columbia. The property is unencumbered by royalties and spans 9 claims totaling 3,924.88 ha British Columbia Mineral Exploration Troy Minerals Inc. Rare-Earth Elements Property Staking
COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 08:12, il y a 2 années 4 mois Original-Research: ecotel communication ag (von Sphene Capital GmbH): Buy Sphene Capital GmbH stuft ecotel communication ag hoch und empfiehlt Kauf mit Kursziel von EUR 40,40. Analyse verdeutlicht positives Mittelfristpotenzial und deutliche Wachstumsprognosen Kaufempfehlung Wachstumspotenzial Sphene Capital GmbH Ecotel Communication AG Mittelfristprognose
COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 08:05, il y a 2 années 4 mois BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps BioNxt Solutions Inc. reports progress in toxicity and PK studies, advancing towards human comparative bioavailability studies. Development includes technology transfer, upscaling, & clinical sample prep for bioequivalence study BioNxt Solutions Inc. Toxicity Studies Comparative Pharmacokinetic Studies Bioavailability Pharmaceutical Drug Market
Publié le 24/07/2026 à 18:50, il y a 15 heures 26 minutes Disclosure of transactions in own shares from July 20 to July 24, 2026
Publié le 24/07/2026 à 18:50, il y a 15 heures 26 minutes Déclaration hebdomadaire d'opérations effectuées du 20 au 24 juillet 2026
Publié le 24/07/2026 à 18:23, il y a 15 heures 53 minutes Communiqué relatif au dépôt d'offre publique de retrait visant les actions Bourrelier Group
Publié le 24/07/2026 à 18:11, il y a 16 heures 5 minutes H1 2026 liquidity contract statement for TF1
Publié le 25/07/2026 à 00:35, il y a 9 heures 42 minutes Pathfinder Ventures Inc. Provides Corporate Update
Publié le 24/07/2026 à 23:00, il y a 11 heures 17 minutes NV Gold Announces Closing of Non-Brokered Private Placement
Publié le 24/07/2026 à 22:15, il y a 12 heures 2 minutes Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Publié le 24/07/2026 à 22:05, il y a 12 heures 12 minutes Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Publié le 24/07/2026 à 20:00, il y a 14 heures 17 minutes Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Publié le 24/07/2026 à 18:44, il y a 15 heures 32 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 24/07/2026 à 18:15, il y a 16 heures 2 minutes EUROPLASMA: Tirage des deux premières tranches du financement obligataire en vue de l’émission de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2 M€
Publié le 24/07/2026 à 17:50, il y a 16 heures 26 minutes Fuller, Smith & Turner PLC: Director / PDMR Shareholding